Virtual Reality Intervention for Fear of Heights
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Boston University Charles River Campus
- Study ID
- NCT06468878
- Status
- Recruiting
Conditions
- Acrophobia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Exposure Intervention Plus Music Induction — BEHAVIORALVR exposure for acrophobia with background music.
- Exposure Intervention With No Music Induction — BEHAVIORALVR exposure for acrophobia with no background music.
Study Details
Exposure-based cognitive behavior therapy is an efficacious treatment for acrophobia (fear of heights) and has been delivered effectively in a virtual reality (VR) environment. The present study is designed to evaluate the effects of liked, non-lyrical background music on the efficacy of a brief VR exposure intervention.
Key Dates
- Start date
- Jul 8, 2024
- Status verified
- Jul 2024
- Primary completion
- May 31, 2025
- Completion
- May 31, 2025
Study Design
- Enrollment
- 44 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Exposure Intervention with Non-Lyrical, Liked Background MusicParticipants will be presented with a list of instrumental songs without lyrics from popular movies. Participants will then rank the songs in order of those they would like to hear the most. During VR heights exposure the participants' highest-ranked songs will be played in the background at a low volume.
- Experimental: Exposure Intervention without Background MusicParticipants will undergo VR heights exposure without background music.
Primary Outcome Measure
Acrophobia (Fear of Heights) [ Time Frame: Comparison of pre-exposure scores to scores from the follow-up survey one week after exposure ]
Central Contacts
- Laura J Long, PhD617-358-4303
- Michael Otto, PhD617-353-9610
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Boston University | Boston | Massachusetts | 02215 | Michael W. Otto, Ph.D. (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Boston, MA
By research site